Navigation Links
Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
Date:8/13/2007

Vitamins C and E and beta carotene, either individually or in combination, do not appear to reduce the risk of cardiovascular events or death among women at high risk for heart disease, according to a report in the August 13/27 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Oxidative damageharm to cells caused by exposure to oxygenmay contribute to the development of cardiovascular disease, according to background information in the article. In addition, compounds known as free radicals may damage artery linings, encourage blood clots and alter the function of blood vessels. Antioxidants scavenge free radicals and limit the damage they can cause, the authors write. Diets high in fruit and vegetable intake, and thus rich in such antioxidants, have been associated with reduced rates of coronary heart disease and stroke. Vitamins C and E and beta carotene are potential mediators of the apparent protective effect of a plant-based diet on cardiovascular disease.

Nancy R. Cook, Sc.D., of Brigham & Womens Hospital and Harvard Medical School, Boston, and colleagues tested the effects of these compounds in the Womens Antioxidant Cardiovascular Study, which followed 8,171 women 40 years or older (average age 60.6) beginning in 1995 to 1996. The women, who either had a history of cardiovascular disease or three or more risk factors, were randomly assigned to take 500 milligrams of ascorbic acid (vitamin C) or placebo every day; 600 international units of vitamin E or placebo every other day; and 50 milligrams of beta carotene or placebo every other day. Participants were followed up for the occurrence of heart events (including stroke, heart attack and bypass surgery) or death through 2005.

During the average study period of 9.4 years, 1,450 women had one or more cardiovascular events, including 274 heart attacks, 298 strokes, 889 coronary revascularization procedures (bypass surgery or angioplasty) and 395 cardiovascular deaths (out of a total 995 deaths). There was no overall effect of ascorbic acid, vitamin E or beta carotene on the primary combined end point or on the individual secondary outcomes of myocardial infarction, stroke, coronary revascularization or cardiovascular disease death, the authors write. There were no significant interactions between agents for the primary end point, but those randomized to both active ascorbic acid and vitamin E experienced fewer strokes.

No additional adverse effects were observed for those taking active pills vs. placebo, with the exception of a small increase in reports of upset stomach among those taking active beta carotene.

Overall, we found no benefit on the primary combined end point for any of the antioxidant agents tested, alone or in combination, the authors conclude. We also found no evidence for harm. While additional research into combinations of agents, particularly for stroke, may be of interest, widespread use of these individual agents for cardiovascular protection does not appear warranted.
'/>"/>

Contact: Lori J. Shanks
617-534-1600
JAMA and Archives Journals
Source:Eurekalert

Related medicine news :

1. Antioxidants protect health tissue in people undergoing radiation therapy.
2. Antioxidants found in chocolates
3. Antioxidants used for longevity
4. Antioxidants found in chocolates
5. Herbs: rich soure of antioxidants
6. Herbs: rich soure of antioxidants
7. Sweet corn releases antioxidants on cooking
8. The Use Of Antioxidants To Diminish Effects of Alcohol During Pregnancy Questioned
9. Commercial grape juices and vinegars found rich in antioxidants
10. Antioxidants in the body protects the airways from diesel exhaust effect
11. Fruit And Vegetable Peels Are Rich Source Of Potent Antioxidants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... ... in North America for the scientific development, healthcare training and clinical application of ... & Scientific Session on September 16-17 in Greenville, SC at the Bon Secours ...
(Date:2/28/2017)... , ... February 28, 2017 , ... ... Inc., a healthcare automation intelligence company based in New York. , “Ensuring an ... the provider’s workflow remains unaltered. Those two fundamental reasons are the reasons this ...
(Date:2/27/2017)... ... February 27, 2017 , ... It’s ... strength, which often leads to a host of health issues, including urinary incontinence. ... Geriatrics Society discovered that good overall muscle strength in older women, particularly ...
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear warfare ... for a company involved in the underground testing of nuclear weapons. Years later, when ... Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes the critical decisions made ...
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines ... despite scientific studies, the Center for Disease Control ( CDC ) and Infectious Diseases ... Kenneth B. Liegner, M.D. has compiled into a single volume a compelling argument that ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017   Royal ... PHIA), a global leader in health technology, today ... Drug Administration (FDA) to market its ElastQ Imaging ... family of ultrasound systems. ElastQ Imaging enables simultaneous ... which is essential for the diagnosis of various ...
(Date:2/27/2017)...  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ) ... th Annual Healthcare Conference on Monday, March 6, ... MA. A live webcast of Infinity,s presentation ... website at www.infi.com , and will be available ... Infinity,Infinity is an innovative biopharmaceutical company dedicated to advancing ...
(Date:2/27/2017)... February 27, 2017 A recent research report ... marijuana market alone is expected to reach a value of $55.8 ... along with 28 states have legalized marijuana for medical uses. ... Florida , North Dakota , ... approved to use the drug in medical applications such as chemotherapies ...
Breaking Medicine Technology: